In recent trading session today, 0.33 million shares of the Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) have been traded, and its beta is 1.27. Most recently the company’s share price was $1.68, and it changed around $0.0 or 0.30% from the last close, which brings the market valuation of the company to $609.11M. LXRX at last check was trading at a discount to its 52-week high of $3.73, offering almost -122.02% off that amount. The share price’s 52-week low was $0.92, which indicates that the recent value has risen by an impressive 45.24% since then. We note from Lexicon Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 2.65 million shares, with the 3-month average coming to 2.87 million.
Lexicon Pharmaceuticals Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.67. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 3 recommended LXRX as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) trade information
Instantly LXRX has been showing a green trend so far today with a performance of 0.30% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.7100 on recent trading dayincreased the stock’s daily price by 1.75%. The company’s shares are currently up 10.13% year-to-date, but still up 6.65% over the last five days. On the other hand, Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) is 0.90% up in the 30-day period. We can see from the shorts that 26.63 million shares have been sold at a short interest cover period of 11.0 day(s).
Lexicon Pharmaceuticals Inc (LXRX) estimates and forecasts
Lexicon Pharmaceuticals Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -18.60 percent over the past six months and at a 12.66% annual growth rate that is well below the industry average of 17.60%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 6.80%.
LXRX Dividends
Lexicon Pharmaceuticals Inc’s next quarterly earnings report is expected to be released on 2024-Nov-06.
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.15% of Lexicon Pharmaceuticals Inc shares, and 79.25% of them are in the hands of institutional investors. The stock currently has a share float of 80.17%. Lexicon Pharmaceuticals Inc stock is held by 172.0 institutions, with ARTAL GROUP S.A. being the largest institutional investor. By 2024-06-30, it held 71.3555% of the shares, which is about 175.1 million shares worth $294.17 million.
FMR LLC, with 15.7656% or 38.69 million shares worth $64.99 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Fidelity Growth Company Fund and Fidelity Growth Company K6 Fund were the top two Mutual Funds as of Aug 31, 2024. The former held 14.58 shares worth $24.28 million, making up 4.03% of all outstanding shares. On the other hand, Fidelity Growth Company K6 Fund held roughly 4.88 shares worth around $8.13 million, which represents about 1.35% of the total shares outstanding.
